Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 538
Gene Symbol: ATP7A
ATP7A
0.320 GeneticVariation group BEFREE He has few neurological symptoms without connective tissue disturbances; and a missense ATP7A variant, p.(Pro852Leu), which results in impaired protein trafficking while the copper transport function is spared. 28657131 2017
Entrez Id: 538
Gene Symbol: ATP7A
ATP7A
0.320 Biomarker group CTD_human Maternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein. 23064757 2012
Entrez Id: 538
Gene Symbol: ATP7A
ATP7A
0.320 Biomarker group CTD_human Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDTC). 22815746 2012
Entrez Id: 538
Gene Symbol: ATP7A
ATP7A
0.320 GeneticVariation group BEFREE Based on review of X-inactivation patterns in female carriers of other X-linked recessive diseases, our findings imply that substantial expression of a mutant ATP7A at the expense of the normal allele could be associated with neurologic symptoms in female carriers of Menkes disease and its allelic variants, occipital horn syndrome, and ATP7A-related distal motor neuropathy. 20497190 2011
Entrez Id: 7915
Gene Symbol: ALDH5A1
ALDH5A1
0.300 Biomarker group CTD_human Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder. 29031482 2018
Entrez Id: 2668
Gene Symbol: GDNF
GDNF
0.300 Therapeutic group CTD_human Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model. 19894114 2010
Entrez Id: 5309
Gene Symbol: PITX3
PITX3
0.300 Biomarker group CTD_human Heterozygous and homozygous mutations in PITX3 in a large Lebanese family with posterior polar cataracts and neurodevelopmental abnormalities. 16565358 2006
Entrez Id: 84735
Gene Symbol: CNDP1
CNDP1
0.300 Biomarker group CTD_human Histopathology of the nervous system in carnosinase enzyme deficiency with mental retardation. 4673339 1972
Entrez Id: 7161
Gene Symbol: TP73
TP73
0.200 Biomarker group CTD_mouse TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor. 24190996 2013
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE Interestingly, ACM from male, but not female MeCP2-Tg mice, displays this neurotoxicity reflecting the gender selectivity of neurological symptoms in mice. 29637441 2018
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 GeneticVariation group BEFREE Rett syndrome (RTT) is caused by MECP2 mutations, resulting in various neurological symptoms. 28394409 2017
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE This minimal protein is able to prevent or reverse neurological symptoms when introduced into MeCP2-deficient mice by genetic activation or virus-mediated delivery to the brain. 29019980 2017
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 AlteredExpression group BEFREE Maintenance of an appropriate level of MeCP2 appears integral to the function of healthy neurons as patients with increased levels of MeCP2, owing to duplication of the Xq28 region encompassing the MECP2 locus, also present with intellectual disability and progressive neurologic symptoms. 26060191 2015
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 GeneticVariation group BEFREE Quantification of plasma F₄-NeuroPs provides a novel RTT marker, related to neurological symptoms severity, mutation type and clinical presentation. 21530498 2011
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE Given the important function of MeCP2 in neuronal development, our data could shed light on how MeCP2 deficiency affects postnatal brain functions and the dynamic changes in the neurological symptoms of RTT. 21330301 2011
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE We propose to implement DNA copy number testing for MECP2 in the current diagnostic testing in all males with moderate to severe mental retardation accompanied by (progressive) neurological symptoms. 18985075 2009
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE Since RS is mostly caused by mutations in the MECP2 gene, transgenic animal models such as the Mecp2-deleted ("Mecp2-null") mouse have been employed to study neurological symptoms and brain function. 17237885 2007
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 GeneticVariation group BEFREE Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. 16080119 2005
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.100 Biomarker group BEFREE Both Mecp2-null mice and mice in which Mecp2 was deleted in brain showed severe neurological symptoms at approximately six weeks of age. 11242117 2001
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 Biomarker group BEFREE To overcome the diagnostic challenge, several clinical signs (Kayser-Fleischer rings, neurologic symptoms) and laboratory features (copper in serum, urine, liver; serum ceruloplasmin; genetic testing) are scored 0 (absent) to 2 (present) and the Leipzig score is calculated. 28433100 2017
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 GeneticVariation group BEFREE Inherited functional deficiencies of ASA cause the lysosomal storage disease (LSD) metachromatic leukodystrophy (MLD), which is characterized by intralysosomal accumulation of sulfatide, progressive neurological symptoms and early death. 21515587 2011
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.070 GeneticVariation group BEFREE Thus, increasing sulfatide storage in ASA(-/-) mice leads to neurological symptoms and morphological alterations that are reminiscent of human MLD. 17728461 2007
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 GeneticVariation group BEFREE Hereditary hyperferritinemias are linked to mutations of three genes: the L-ferritin gene responsible for the hereditary hyperferritinemia cataract syndrome (without iron overload), the ferroportin gene leading to a dominant form of iron overload, and the ceruloplasmin (CP) gene corresponding to an iron overload syndrome with neurological symptoms. 15842597 2005
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 AlteredExpression group BEFREE The diagnosis of neurological disease is straightforward if the following symptoms are present: Kayser-Fleischer rings, typical neurological symptoms and low serum ceruloplasmin levels. 14723607 2004
Entrez Id: 1356
Gene Symbol: CP
CP
0.070 Biomarker group BEFREE Most of these findings were consistent with the newly established autosomal recessive disease "aceruloplasminaemia", except for the presence of serum Cp and the lack of apparent neurological symptoms. 11909923 2002